Antidepressant Withdrawal and Hyperbolic Tapering: The Method Most People Were Never Taught

For years, stopping an antidepressant was framed as a quick, simple wind-down. Many people found the reality harder: dizziness, "brain zaps," anxiety and insomnia that dragged on far longer than the couple of weeks they were promised. The science has caught up with their experience, and the result is a smarter approach called hyperbolic tapering, now backed by major guidelines. This guide explains what withdrawal really involves and how the curved-taper method reduces it.

In short

• Stopping some antidepressants causes withdrawal symptoms that, for a subset of people, are more intense and longer-lasting than the old advice suggested.
• Hyperbolic tapering reduces the dose in progressively smaller steps, matching how the drug actually acts on the brain.
• The practical rule is to cut by a percentage of the current dose, not a fixed amount, so reductions get smaller as you go down.
• Microtapering, tiny frequent reductions, is a gentler version of the same idea.
• This approach is now supported by the Maudsley Deprescribing Guidelines and clinical guidance, and it is done with a prescriber, not alone.

Why is coming off harder than people were told?

Because the brain adapts to an antidepressant, and removing it too quickly leaves that adaptation exposed, producing withdrawal symptoms that can last weeks or longer. Discontinuation symptoms include dizziness, electric-shock sensations often called brain zaps, mood swings, irritability, insomnia and flu-like feelings. For many people they are mild and brief. For a meaningful minority, especially after longer use or with shorter-acting drugs like paroxetine or venlafaxine, they are severe and prolonged. Recognising this was the shift: withdrawal is real and variable, not a sign the depression is returning in every case.

What is hyperbolic tapering?

It is a way of reducing the dose in ever-smaller steps so that each cut has roughly the same effect on the brain, rather than the same size in milligrams. The reason is biological. The relationship between an antidepressant dose and its effect on brain receptors is not a straight line; it is a curve that flattens at higher doses. So going from 20 mg to 15 mg barely changes receptor occupancy, while going from 5 mg to 0 mg changes it enormously. Guidance from the Psychopharmacology Institute explains this curve. A hyperbolic taper mirrors it, taking bigger milligram cuts at the top and much smaller ones near the bottom.

How does it work in practice?

You reduce by a percentage of your most recent dose rather than by a fixed amount, which automatically makes each step smaller as the dose falls. A common approach is to cut around 10 percent of the current dose at each step, wait for stability, then cut again. Because it is a percentage, 10 percent of 20 mg is a 2 mg step, but later 10 percent of 5 mg is only 0.5 mg. Near the very bottom the steps become tiny, which is where liquid formulations or counting the small beads inside a capsule come in, so people can make reductions far smaller than the available tablet strengths allow. Tapering strips and compounded liquids exist for exactly this reason.

What is microtapering?

Microtapering makes very small reductions very frequently, for example a fraction of a dose each day, to smooth out the destabilisation that bigger monthly cuts can cause. Instead of a noticeable drop once a month, the dose eases down almost continuously. Some people find this gentler because no single reduction is large enough to trigger a wave of symptoms. It follows the same hyperbolic logic, just in smaller and more frequent increments, and it slows down further as the dose approaches zero.

Is this an official recommendation?

Yes. Hyperbolic tapering has moved from patient forums into mainstream clinical guidance. It is now supported by the Maudsley Deprescribing Guidelines published in 2024 and reflected in clinical guidance on stopping antidepressants, and outcomes have been studied, as in this PMC paper on hyperbolic tapering. That matters because it means asking your prescriber for a slower, curved taper is not a fringe request; it is in line with current best practice. It also means you should not attempt it alone: the whole point is a structured, monitored reduction, ideally with the right formulations to make small steps possible.

The bottom line

If you have struggled to come off an antidepressant, or you are dreading it, the problem may have been the speed and shape of the taper, not your resolve or your underlying condition. Hyperbolic and micro tapering match the reduction to how the drug actually leaves the brain, and they are now backed by guidelines. Bring this approach to your prescriber, cover sertraline, escitalopram or whichever medicine you take, and plan it together. Our antidepressants and mental health pages give the wider context.

This article is educational and does not replace advice from a doctor or pharmacist who knows your health history.